The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
Clorox Co (NYSE: CLX) closed the day trading at $101.42 up 0.49% from the previous closing price of $100.93. In other words, the price has increased by $0.49 from its previous closing price. On the day, 1.92 million shares were traded. CLX stock price reached its highest trading level at $102.98 during the session, while it also had its lowest trading level at $101.06.
Ratios:
For a better understanding of CLX, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 74.53 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 19.45. For the most recent quarter (mrq), Quick Ratio is recorded 0.50 and its Current Ratio is at 0.76.
Upgrades & Downgrades
In the most recent recommendation for this company, Barclays on October 01, 2025, Reiterated its Underweight rating but revised its target price to $112 from $118 previously.
On January 07, 2025, Wells Fargo Upgraded its rating to Equal Weight which previously was Underweight but kept the price unchanged to $157.
TD Cowen Upgraded its Sell to Hold on November 06, 2024, whereas the target price for the stock was revised from $155 to $170.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 21 ’25 when Breber Pierre R bought 4,000 shares for $104.13 per share. The transaction valued at 416,516 led to the insider holds 13,000 shares of the business.
Reynolds Eric H sold 15,041 shares of CLX for $1,861,847 on Sep 04 ’25. The EVP – Chief Operating Officer now owns 54,221 shares after completing the transaction at $123.78 per share. On Sep 04 ’25, another insider, Eric Reynolds, who serves as the Officer of the company, bought 15,041 shares for $123.78 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLX now has a Market Capitalization of 12371249152 and an Enterprise Value of 15383479296. As of this moment, Clorox’s Price-to-Earnings (P/E) ratio for their current fiscal year is 15.89, and their Forward P/E ratio for the next fiscal year is 14.99. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.83. Its current Enterprise Value per Revenue stands at 2.272 whereas that against EBITDA is 12.558.
Stock Price History:
The Beta on a monthly basis for CLX is 0.58, which has changed by -0.38703996 over the last 52 weeks, in comparison to a change of 0.12529528 over the same period for the S&P500. Over the past 52 weeks, CLX has reached a high of $169.61, while it has fallen to a 52-week low of $98.20. The 50-Day Moving Average of the stock is -8.93%, while the 200-Day Moving Average is calculated to be -20.05%.
Shares Statistics:
Over the past 3-months, CLX traded about 1.96M shares per day on average, while over the past 10 days, CLX traded about 2038520 shares per day. A total of 121.78M shares are outstanding, with a floating share count of 121.38M. Insiders hold about 0.49% of the company’s shares, while institutions hold 87.97% stake in the company. Shares short for CLX as of 1763078400 were 6743777 with a Short Ratio of 3.44, compared to 1760486400 on 6448324. Therefore, it implies a Short% of Shares Outstanding of 6743777 and a Short% of Float of 6.36.
Dividends & Splits
CLX’s forward annual dividend rate is 4.92, up from 4.92 a year ago. Against a Trailing Annual Dividend Yield of 0.048746657. The stock’s 5-year Average Dividend Yield is 3.16. The current Payout Ratio is 75.19% for CLX, which recently paid a dividend on 2025-10-22 with an ex-dividend date of 2026-01-28. Stock splits for the company last occurred on 1999-08-24 when the company split stock in a 2:1 ratio.
Earnings Estimates
A detailed examination of Clorox Co (CLX) is currently in progress, with 14.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is $1.57, with high estimates of $1.77 and low estimates of $1.41.
Analysts are recommending an EPS of between $6.82 and $5.4 for the fiscal current year, implying an average EPS of $5.99. EPS for the following year is $6.77, with 18.0 analysts recommending between $7.22 and $6.2.
Revenue Estimates
12 analysts predict $1.64B in revenue for. The current quarter. It ranges from a high estimate of $1.65B to a low estimate of $1.63B. As of. The current estimate, Clorox Co’s year-ago sales were $1.69BFor the next quarter, 12 analysts are estimating revenue of $1.67B. There is a high estimate of $1.7B for the next quarter, whereas the lowest estimate is $1.64B.
A total of 17 analysts have provided revenue estimates for CLX’s current fiscal year. The highest revenue estimate was $6.6B, while the lowest revenue estimate was $6.43B, resulting in an average revenue estimate of $6.5B. In the same quarter a year ago, actual revenue was $7.1BBased on 17 analysts’ estimates, the company’s revenue will be $6.81B in the next fiscal year. The high estimate is $6.92B and the low estimate is $6.65B.
